• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Nuvo Research Inc

+ Add to Watchlist

DLAN:GR

3.326 EUR 0.160 5.05%

As of 03:10:36 ET on 09/23/2014.

Snapshot for Nuvo Research Inc (DLAN)

Open: 3.144 Day's Range: 3.144 - 3.326 Volume: 0
Previous Close: 3.166 52wk Range: 0.948 - 3.448 1-Yr Rtn: +133.73%

Stock Chart for DLAN

No chart data available.
  • DLAN:GR 3.326
  • 1D
  • 1M
  • 1Y
3.166
Interactive DLAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DLAN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 34.06
Shares Outstanding (M) 10.24
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DLAN

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for DLAN

Nuvo Research Inc. manufactures drugs in Canada and Germany. The Company develops and manufactures products aimed at treatment options for arthritis, skin conditions, certain cancers, immune system response, and the therapeutic management of chronic viral infections.

Daniel H ChicoineChairman/Co-CEOJohn C LondonPresident/Co-CEO
Henrich R K GuntermannPresident:Europe & ImmunologyStephen L LemieuxVP/CFO
More Company Profile & Key Executives for DLAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil